“Floppy iris syndrome as a complication of the use of an alpha-adrenergic blocker for the treatment of benign prostatic hyperplasia”, RSD, vol. 10, no. 14, p. e121101421626, Nov. 2021, doi: 10.33448/rsd-v10i14.21626.